It seems they are buying back 420,000 shares for a price range of $2.37 to $3.22 from Executives that have left the business.Paying above market value is a further sign that they believe the shares are way undervalued.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025